+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 65Years
All Genders
ID06805656

Evaluating Combined Treatment Strategies to Reduce HIV Reservoirs and Achieve Sustained Remission Without Antiretroviral Therapy

Led by Federal University of São Paulo · Updated on 2026-08-19

70

Participants Needed

1

Research Sites

65 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating combined strategies to reduce the HIV proviral reservoir size in people with HIV who have been on suppressive antiretroviral treatment. The study aims to achieve sustained HIV remission without the need for ongoing antiretroviral medications by testing a combination of treatments that target viral latency and infected cells. This is a Phase 2 clinical trial supported by the Federal University of So Paulo. Participants will be randomly assigned to one of two groups. One group will receive no further intervention and continue their current treatment. The other group will undergo intensified antiretroviral therapy with dolutegravir and maraviroc, along with additional treatments including a histone deacetylase inhibitor nicotinamide for 48 weeks, gold salt auranofin for the last 24 weeks, and a personalized dendritic cell vaccine. This combination aims to disrupt viral latency and reduce the HIV reservoir. During the study, participants will be closely monitored with regular measurements of HIV viral load, total and episomal HIV DNA, and cell-associated HIV RNA in blood cells over baseline and several weeks up to 36 months after stopping antiretroviral treatment. Additional assessments include lymphoid tissue biopsies and immune cell activation markers. The research team will also track plasma cytokine levels and bacterial translocation markers. These evaluations will help understand the effects of the interventions and treatment interruption on HIV reservoirs and immune health.

CONDITIONS

Brief Title

Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without Antiretrovirals

Research Team

R

Ricardo S Diaz, M.D.; PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here